Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clearone (CLRO) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Clearone (CLRO) over the last 15 years, with Sep 2025 value amounting to $663,000.

  • Clearone's Cash & Equivalents fell 60.65% to $663,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $663,000, marking a year-over-year decrease of 60.65%. This contributed to the annual value of $1.4 million for FY2024, which is 92.05% down from last year.
  • According to the latest figures from Q3 2025, Clearone's Cash & Equivalents is $663,000, which was down 60.49% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Clearone's Cash & Equivalents peaked at $59.0 million during Q1 2023, and registered a low of $663,000 during Q3 2025.
  • Moreover, its 3-year median value for Cash & Equivalents was $8.1 million (2023), whereas its average is $13.2 million.
  • As far as peak fluctuations go, Clearone's Cash & Equivalents spiked by 4,049.51% in 2023, and later plummeted by 92.05% in 2024.
  • Clearone's Cash & Equivalents (Quarterly) stood at $1.1 million in 2021, then dropped by 8.12% to $984,000 in 2022, then soared by 1,712.50% to $17.8 million in 2023, then crashed by 92.05% to $1.4 million in 2024, then crashed by 60.65% to $663,000 in 2025.
  • Its Cash & Equivalents was $663,000 in Q3 2025, compared to $1.7 million in Q2 2025 and $1.4 million in Q4 2024.